Skip to content

Clinical trials

Huntington Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Huntington Disease Country / region: Italy Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20081
20121
20142
20151
20171
20192
20201
20211
20222
20232
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting5
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Prilenia4
Hoffmann-La Roche3
Novartis Pharmaceuticals3
Teva Branded Pharmaceutical Products R&D, Inc.2
CHDI Foundation, Inc.1
European Huntington's Disease Network1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1
IRCCS Policlinico S. Donato1
SOM Innovation Biotech SA1
University College, London1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Huntington Disease19
Rare Diseases3
Neurodegenerative Diseases2
Angioedema1
Chorea1
Heart Defects, Congenital1
Marfan Syndrome1

Trials

Showing 26 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.